C4 Projects Revenue and Competitors
Estimated Revenue & Valuation
- C4 Projects's estimated annual revenue is currently $82.5k per year.
- C4 Projects's estimated revenue per employee is $41,250
Employee Data
- C4 Projects has 2 Employees.
- C4 Projects grew their employee count by -71% last year.
C4 Projects's People
Name | Title | Email/Phone |
---|
C4 Projects Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.5M | 26 | 8% | N/A | N/A |
#2 | $3.9M | 52 | 11% | N/A | N/A |
#3 | $40.4M | 392 | 6% | N/A | N/A |
#4 | $9.1M | 110 | -1% | N/A | N/A |
#5 | $111.5M | 965 | 27% | N/A | N/A |
#6 | $6.8M | 83 | -31% | N/A | N/A |
#7 | $0.3M | 8 | 0% | N/A | N/A |
#8 | $0.9M | 19 | 0% | N/A | N/A |
#9 | $0.5M | 11 | 10% | N/A | N/A |
#10 | $6.8M | 83 | 14% | N/A | N/A |
What Is C4 Projects?
From tech newbie to professional developer, we mentor your journey to success!
keywords:N/AN/A
Total Funding
2
Number of Employees
$82.5k
Revenue (est)
-71%
Employee Growth %
N/A
Valuation
N/A
Accelerator
C4 Projects News
2022-04-17 - With Funds from the American Rescue Plan Act, Mayor Walsh Opens
Applications for Commercial Corridor Improvement Fund
Applicants can be for-profit and nonprofit/501c3 or c4 organizations. All proposed project sites must be located within a qualified ARPA...
2022-04-06 - AACR: The Weekend Losers According to Wall Street
... early data from their respective research projects. We look into each one below: C4 Shares More than Halved On Multiple Myeloma Data.
2022-04-06 - AACR: C4's multiple myeloma data prompt dosing switch ...
C4 Therapeutics has learned a lot from just five multiple myeloma patients ... knowledge graph in drug discovery projects in collaboration with industry...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 3 | 50% | N/A |
#2 | N/A | 27 | 4% | N/A |
#3 | N/A | 54 | 26% | N/A |
#4 | $11.2M | 77 | -13% | N/A |
#5 | N/A | 79 | 27% | N/A |